IL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouse.

IL-6, IL-17 and Stat3 are required for auto-inflammatory syndrome development in mouse.
复制标题

DOI:
10.1038/s41598-018-34173-5
复制
发表时间:
2018-10-25
期刊:
影响因子:
4.6
通讯作者:
Miyamoto T
Miyamoto T
中科院分区:
综合性期刊3区
文献类型:
--
作者:
Oike T;Kanagawa H;Sato Y;Kobayashi T;Nakatsukasa H;Miyamoto K;Nakamura S;Kaneko Y;Kobayashi S;Harato K;Yoshimura A;Iwakura Y;Takeuchi T;Matsumoto M;Nakamura M;Niki Y;Miyamoto T

文献摘要

参考文献

被引文献

相似文献

自身炎性综合征是一种临床上与类风湿性关节炎不同的病症,其特征在于组织如主要关节、皮肤和内脏中的全身性炎症。自主性先天免疫激活被认为会促进这种炎症,但潜在的病理机制尚未阐明,治疗策略也尚未建立。在这里,我们新建立了一个小鼠模型,其中IL-1信号在成年小鼠(hIL-1 cTg)中被条件性激活,并观察到与自身炎症综合征患者相似的表型。hIL-1 cTg小鼠血清中IL-6和IL-17水平显著升高,关节中信号转导和转录激活因子3(Stat 3)被激活。当我们将hIL-1 cTg与IL-6或IL-17缺陷小鼠或Stat 3条件性敲除小鼠杂交时,在hIL-1 cTg小鼠中观察到的表型显著改善。因此,IL-6、IL-17和Stat 3都代表了该综合征的潜在治疗靶点。
Auto-inflammatory syndrome, a condition clinically distinct from rheumatoid arthritis, is characterized by systemic inflammation in tissues such as major joints, skin, and internal organs. Autonomous innate-immune activation is thought to promote this inflammation, but underlying pathological mechanisms have not been clarified nor are treatment strategies established. Here, we newly established a mouse model in which IL-1 signaling is conditionally activated in adult mice (hIL-1 cTg) and observed phenotypes similar to those seen in auto-inflammatory syndrome patients. In serum of hIL-1 cTg mice, IL-6 and IL-17 levels significantly increased, and signal transducer and activator of transcription 3 (Stat3) was activated in joints. When we crossed hIL-1 cTg with either IL-6- or IL-17-deficient mice or with Stat3 conditional knockout mice, phenotypes seen in hIL-1 cTg mice were significantly ameliorated. Thus, IL-6, IL-17 and Stat3 all represent potential therapeutic targets for this syndrome.
DOI: 10.1186/s41232-017-0050-9
发表时间: 2017
影响因子: 8.1
作者:
Karasawa T;Takahashi M
通讯作者: Takahashi M
DOI: 10.1016/j.cell.2010.03.002
发表时间: 2010-03-19
期刊: Cell
影响因子: 64.5
作者:
Kastner DL;Aksentijevich I;Goldbach-Mansky R
通讯作者: Goldbach-Mansky R
DOI: 10.1056/nejmoa1112802
发表时间: 2012-12-20
影响因子: 158.5
作者:
De Benedetti, Fabrizio;Brunner, Hermine I.;Martini, Alberto
通讯作者: Martini, Alberto
DOI: 10.1093/rheumatology/keu430
发表时间: 2015-06-01
期刊: RHEUMATOLOGY
影响因子: 5.5
作者:
Isomaki, Pia;Junttila, Ilkka;Silvennoinen, Olli
通讯作者: Silvennoinen, Olli
DOI: 10.1056/nejmoa0807865
发表时间: 2009-06-04
期刊: The New England journal of medicine
影响因子: --
作者:
Aksentijevich I;Masters SL;Ferguson PJ;Dancey P;Frenkel J;van Royen-Kerkhoff A;Laxer R;Tedgård U;Cowen EW;Pham TH;Booty M;Estes JD;Sandler NG;Plass N;Stone DL;Turner ML;Hill S;Butman JA;Schneider R;Babyn P;El-Shanti HI;Pope E;Barron K;Bing X;Laurence A;Lee CC;Chapelle D;Clarke GI;Ohson K;Nicholson M;Gadina M;Yang B;Korman BD;Gregersen PK;van Hagen PM;Hak AE;Huizing M;Rahman P;Douek DC;Remmers EF;Kastner DL;Goldbach-Mansky R
通讯作者: Goldbach-Mansky R